Sign in

NCT07080697Recruiting

A Study to Evaluate Splenectomy on Debridement for Acute Necrotizing Pancreatitis With Pancreatic Sinistral Portal Hypertension

The Impact of Splenectomy on Debridement Efficacy, Perioperative Recovery, and Prognosis in Patients With Acute Necrotizing Pancreatitis Complicated by Pancreatic Sinistral Portal Hypertension

Source: ClinicalTrials.gov · Last updated 23 Jul 2025 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

This study is a prospective, single-center, randomized controlled trial focusing on patients with acute necrotizing pancreatitis (ANP) complicated by pancreatic sinistral portal hypertension (PSPH). The study aims to study the impact of total splenectomy on the debridement efficacy, perioperative recovery, and prognosis of patients with ANP complicated by PSPH.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
66 (estimated)
First submitted
4 Jul 2025
Start date
30 Jul 2025
Primary completion date
28 Feb 2027
Lead sponsor
Zhejiang University
NCT number
NCT07080697

What you commit to

  • Study type: Interventional
  • Planned participants: 66
  • From 30 Jul 2025 to the primary completion date, 28 Feb 2027
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Patients with pre-existing heart, lung, liver, kidney, or other organ failure prior to acute pancreatitis (AP).
  • Patients with pre-existing conditions such as cirrhosis that may lead to portal hypertension prior to AP.
  • Patients with pre-existing hematological diseases prior to AP.

Other

  • Patients undergoing laparoscopic or nephroscopic debridement.

Who the study is looking for

  • Age between 18 and 75 years.
  • Acute necrotic pancreatitis complicated by pancreatic sinistral portal hypertension.
  • Patients undergoing open debridement for infected pancreatic necrosis

Age in the registry: 18 years to 75 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
First Affiliated Hospital, Zhejiang University School of Medicine
Coordinator of this site? Confirm its status
HangzhouChinaRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.